208 related articles for article (PubMed ID: 6460339)
1. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
Cofrancesco E; Vigo A; Pogliani EM
Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
[TBL] [Abstract][Full Text] [Related]
2. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
Tran TH; Bondeli C; Marbet GA; Duckert F
Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
[TBL] [Abstract][Full Text] [Related]
4. Role of heparin in the inactivation of thrombin, factor Xa, and plasmin by antithrombin III.
Stürzebecher J; Markwardt F
Thromb Res; 1977 Dec; 11(6):835-46. PubMed ID: 146278
[No Abstract] [Full Text] [Related]
5. Adverse effect of heparin in thrombin-antithrombin III interaction.
Marciniak E
Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
[TBL] [Abstract][Full Text] [Related]
7. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
Blaskó G
Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
[TBL] [Abstract][Full Text] [Related]
10. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
12. The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.
Osterud B; Miller-Andersson M; Abildgaard U; Prydz H
Thromb Haemost; 1976 Apr; 35(2):295-304. PubMed ID: 61631
[TBL] [Abstract][Full Text] [Related]
13. Role of heparin in the interaction of serine proteinases with antithrombin III.
Stürzebecher J
Acta Biol Med Ger; 1977; 36(11-12):1893-7. PubMed ID: 151469
[TBL] [Abstract][Full Text] [Related]
14. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T
Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876
[TBL] [Abstract][Full Text] [Related]
15. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.
Ofosu FA; Modi GJ; Smith LM; Cerskus AL; Hirsh J; Blajchman MA
Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872
[TBL] [Abstract][Full Text] [Related]
16. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
Bhargava AS; Heinick J; Günzel P
Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
[TBL] [Abstract][Full Text] [Related]
18. Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber.
Li Z; Wang H; Li J; Zhang G; Gao C
Chin Med J (Engl); 2000 Aug; 113(8):706-11. PubMed ID: 11776053
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
Meddahi S; Bara L; Fessi H; Samama MM
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
